Company / Operating Income per Share
BioAge Labs, Inc. Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.59
FY2025
5-year range
-$28.93 / -$2.59
FY2023-FY2025
Trend
+64.5%
vs FY2024
Sector context
#133 of 201
Health Care
What the data says
At $-2.59, BioAge Labs, Inc.'s operating income per share ranks #133 of 201 in the Health Care sector. Improved from $-28.93 to $-2.59 over the past 2 years.
Based on SEC 10-K filings.
-2.59 in FY2025.
Improved from $-28.93 to $-2.59 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#133 of 201 in Health CareTop 66% of 201This company -$2.59 Sector average -$28.56
▼
+90.9% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 64.5% year-over-year.
- Ranks #133 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.59 | +64.5% |
| FY2024 | -$7.29 | +74.8% |
| FY2023 | -$28.93 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026